Dr. Millikan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
400 E 3RD ST ESSENTIA HEALTH DULUTH CLINIC
Duluth, MN 55805Phone+1 218-786-3625- Is this information wrong?
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1988 - 1991
University of Miami Leonard M. Miller School of MedicineClass of 1988
Certifications & Licensure
IL State Medical License 2022 - 2026
MN State Medical License 2013 - 2024
WA State Medical License 2020 - 2023
UT State Medical License 2019 - 2022
OR State Medical License 2020 - 2022
TX State Medical License 1994 - 2013- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2008
- America's Top Doctors for Cancer Castle Connolly, 2005-2007
Clinical Trials
- Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer Start of enrollment: 1996 Aug 01
- Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer Start of enrollment: 1997 Dec 01
- Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium Start of enrollment: 2001 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 11 citationsThe combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate...Farshid Dayyani, Amado J. Zurita, Graciela M. Nogueras-Gonzalez, Rebecca Slack, Randall E. Millikan, John C. Araujo, Gary E. Gallick, Christopher J. Logothetis, Paul G...> ;BMC Cancer. 2016 Sep 6
- 35 citationsA Phase l Study of a Tumor-targeted Systemic Nanodelivery System, SGT-94, in Genitourinary Cancers.Arlene O. Siefker-Radtke, Xin Qiao Zhang, Charles C. Guo, Yu Shen, Kathleen F. Pirollo, Sharjeel H. Sabir, Chris P. Leung, Cindy Leong-Wu, Chi Ming Ling, Esther H. Cha...> ;Molecular Therapy. 2016 Aug 1
- 199 citationsA Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naive Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chem...David J. McConkey, Woonyoung Choi, Yu Shen, I. Ling Lee, Sima P. Porten, Surena F. Matin, Ashish M. Kamat, Paul G. Corn, Randall E. Millikan, Colin P.N. Dinney, Bogdan...> ;European Urology. 2016 May 1
- Join now to see all
Other
- Experimental systemic therapy of metastatic bladder cancerMillikan RE
http://www.uptodate.com/contents/experimental-systemic-therapy-of-metastatic-bladder-cancer
UpToDate, Wolters Kluwer Health - 2012-09-25
Grant Support
- Neoadjuvant Therapy For Advanced Bladder CancerNational Cancer Institute1996–1999
Hospital Affiliations
Providence St. Mary Medical CenterWalla Walla, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
